In an apparent move to shed a non-core business, Merck & Co has decided that it no longer wants to run its own in-house capability for the contract manufacture of biologics, although it will still have access to the operations that it has built up in this sector.
Fujifilm is to buy for undisclosed terms the Merck BioManufacturing Network, the US giant's wholly owned contract biologics manufacturing and...